Locus Biosciences
PrivateLast Round
Grant
Jan 7, 2026
Total Funding Raised
$142.88M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Locus Biosciences is a biotechnology company that develops engineered bacteriophage-based products aimed at precisely eliminating pathogenic bacteria from the human body through the innovative use of CRISPR-Cas3 technology and safe delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Locus Biosciences Comparables
Compare Locus Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SNIPR Biome | 87% | |
| Eligo Bioscience | 87% | |
| BiomX Inc. | 85% | |
Locus Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 7, 2026 | ||||
| Grant | Jan 23, 2024 | ||||
| Series B | May 18, 2022 | ||||
| Debt | Oct 19, 2021 | ||||
| Grant | Nov 10, 2020 | ||||
Corporate Funding | Sep 30, 2020 |
Key People
Founding team and executive leadership
Locus Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Debt |
| National Institute of Allergy and Infectious Diseases | Grant |
| CARB-X | Grant |
| ARTIS Ventures | Series B, Series A |
| Public Health Emergency Medical Countermeasures Enterprise | Grant, Corporate Funding |
| Abstract Ventures | Series A |
| Viking Global Investors | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
$24M grant awarded by BARDA and PHME.
- Oct 28, 2025
Developing therapies for ophthalmic bacterial infections with Viatris.
Locus Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Locus Biosciences's valuation, stock price, and market status.